Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.170
+0.020 (1.74%)
Jul 31, 2026, 4:08 PM HKT
Cloudbreak Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 40.15 | 34.86 | 52.65 | 15.92 |
Short-Term Investments | - | - | 7.5 | 63.19 |
Trading Asset Securities | 18.2 | - | - | - |
Cash & Short-Term Investments | 58.35 | 34.86 | 60.15 | 79.11 |
Cash Growth | 67.38% | -42.05% | -23.96% | - |
Other Receivables | 2.43 | 2.09 | 0.77 | 0.81 |
Receivables | 2.43 | 2.09 | 0.77 | 0.81 |
Inventory | 0.11 | - | - | - |
Prepaid Expenses | 3.38 | 0.05 | 0.17 | 0.18 |
Other Current Assets | 0.06 | 0.51 | 0.37 | 0.01 |
Total Current Assets | 64.34 | 37.51 | 61.47 | 80.11 |
Property, Plant & Equipment | 2.22 | 2.43 | 3.27 | 1.17 |
Other Long-Term Assets | 0.04 | 0.07 | 0.1 | 0.81 |
Total Assets | 66.61 | 40.01 | 64.83 | 82.09 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 0.84 | 1.76 | 2.1 | 1.23 |
Accrued Expenses | 4.48 | 2.06 | 1.72 | 1.85 |
Short-Term Debt | 0.44 | 386.2 | 322.46 | 109.96 |
Current Portion of Leases | 0.22 | 0.3 | 0.32 | 0.29 |
Current Income Taxes Payable | 0.04 | 0.08 | 0.02 | - |
Other Current Liabilities | - | 0.95 | 0.78 | 113.38 |
Total Current Liabilities | 6.02 | 391.35 | 327.4 | 226.7 |
Long-Term Leases | 0.1 | 0.21 | 0.23 | 0.55 |
Total Liabilities | 6.12 | 391.56 | 327.63 | 227.25 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.08 | 0.05 | 0.05 | 0.05 |
Additional Paid-In Capital | 686.29 | 258.28 | 258.28 | 258.28 |
Retained Earnings | -411.91 | -344.25 | -245.12 | -115.7 |
Comprehensive Income & Other | -213.97 | -265.62 | -276 | -287.79 |
Shareholders' Equity | 60.49 | -351.55 | -262.79 | -145.16 |
Total Liabilities & Equity | 66.61 | 40.01 | 64.83 | 82.09 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 0.76 | 386.71 | 323 | 110.8 |
Net Cash (Debt) | 57.59 | -351.84 | -262.85 | -31.69 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | 0.09 | -0.74 | -0.57 | -0.07 |
Filing Date Shares Outstanding | 844.57 | 475.39 | 462.54 | 458.6 |
Total Common Shares Outstanding | 844.57 | 475.39 | 462.54 | 458.6 |
Working Capital | 58.32 | -353.84 | -265.93 | -146.59 |
Book Value Per Share | 0.07 | -0.74 | -0.57 | -0.32 |
Tangible Book Value | 60.49 | -351.55 | -262.79 | -145.16 |
Tangible Book Value Per Share | 0.07 | -0.74 | -0.57 | -0.32 |
Machinery | 0.98 | 0.84 | 0.75 | 0.36 |
Leasehold Improvements | 1.05 | 1.04 | 1.01 | 0.16 |